Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | HCM |
---|---|---|
09:32 ET | 759 | 21.79 |
09:34 ET | 100 | 21.37 |
09:36 ET | 219 | 21.42 |
09:39 ET | 400 | 21.57 |
09:41 ET | 562 | 21.54 |
09:45 ET | 300 | 21.48 |
09:48 ET | 1500 | 21.4434 |
09:50 ET | 100 | 21.46 |
09:52 ET | 100 | 21.44 |
09:54 ET | 200 | 21.52 |
09:57 ET | 100 | 21.46 |
09:59 ET | 100 | 21.465 |
10:01 ET | 505 | 21.4 |
10:03 ET | 200 | 21.4 |
10:06 ET | 1300 | 21.42 |
10:08 ET | 975 | 21.42 |
10:10 ET | 180 | 21.44 |
10:15 ET | 100 | 21.42 |
10:17 ET | 300 | 21.45 |
10:19 ET | 200 | 21.43 |
10:21 ET | 300 | 21.4 |
10:26 ET | 100 | 21.35 |
10:30 ET | 200 | 21.315 |
10:33 ET | 100 | 21.31 |
10:35 ET | 664 | 21.46 |
10:39 ET | 100 | 21.385 |
10:46 ET | 100 | 21.35 |
10:53 ET | 100 | 21.35 |
10:55 ET | 5928 | 21.45 |
10:57 ET | 6675 | 21.545 |
11:00 ET | 143 | 21.525 |
11:02 ET | 100 | 21.495 |
11:08 ET | 100 | 21.46 |
11:09 ET | 100 | 21.45 |
11:13 ET | 110 | 21.45 |
11:15 ET | 100 | 21.5 |
11:20 ET | 200 | 21.39 |
11:26 ET | 715 | 21.465 |
11:33 ET | 100 | 21.46 |
11:36 ET | 109 | 21.45 |
11:38 ET | 530 | 21.51 |
11:42 ET | 100 | 21.47 |
11:47 ET | 100 | 21.44 |
11:51 ET | 100 | 21.48 |
12:02 ET | 1095 | 21.45 |
12:07 ET | 100 | 21.45 |
12:16 ET | 295 | 21.45 |
12:21 ET | 113 | 21.445 |
12:25 ET | 414 | 21.41 |
12:30 ET | 706 | 21.35 |
12:36 ET | 200 | 21.36 |
12:59 ET | 100 | 21.34 |
01:10 ET | 100 | 21.3 |
01:14 ET | 100 | 21.31 |
01:15 ET | 1133 | 21.33 |
01:28 ET | 115 | 21.3 |
01:32 ET | 213 | 21.36 |
01:46 ET | 100 | 21.37 |
01:51 ET | 100 | 21.33 |
02:02 ET | 100 | 21.32 |
02:04 ET | 918 | 21.36 |
02:06 ET | 500 | 21.4 |
02:08 ET | 1750 | 21.375 |
02:09 ET | 1017 | 21.4 |
02:11 ET | 3725 | 21.39 |
02:15 ET | 3785 | 21.43 |
02:18 ET | 200 | 21.45 |
02:24 ET | 233 | 21.45 |
02:27 ET | 500 | 21.46 |
02:29 ET | 300 | 21.4775 |
02:31 ET | 300 | 21.45 |
02:40 ET | 100 | 21.43 |
02:44 ET | 100 | 21.42 |
02:51 ET | 100 | 21.39 |
02:54 ET | 100 | 21.36 |
03:00 ET | 117 | 21.34 |
03:02 ET | 100 | 21.3689 |
03:03 ET | 2113 | 21.38 |
03:09 ET | 300 | 21.4 |
03:12 ET | 106 | 21.385 |
03:18 ET | 100 | 21.39 |
03:21 ET | 112 | 21.36 |
03:23 ET | 100 | 21.36 |
03:25 ET | 315 | 21.38 |
03:27 ET | 4563 | 21.39 |
03:30 ET | 816 | 21.4 |
03:34 ET | 200 | 21.41 |
03:36 ET | 616 | 21.45 |
03:38 ET | 200 | 21.45 |
03:41 ET | 600 | 21.42 |
03:43 ET | 400 | 21.405 |
03:45 ET | 309 | 21.39 |
03:48 ET | 213 | 21.36 |
03:50 ET | 100 | 21.39 |
03:52 ET | 1500 | 21.41 |
03:54 ET | 418 | 21.41 |
03:56 ET | 1330 | 21.38 |
03:57 ET | 862 | 21.39 |
03:59 ET | 1658 | 21.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
HUTCHMED (China) Ltd | 3.9B | 37.2x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -43.5x | --- |
Amphastar Pharmaceuticals Inc | 2.1B | 14.2x | --- |
Corcept Therapeutics Inc | 2.9B | 25.9x | +9.80% |
Pacira Biosciences Inc | 1.4B | 23.8x | --- |
Tilray Brands Inc | 1.6B | -4.2x | --- |
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9B |
---|---|
Revenue (TTM) | $838.0M |
Shares Outstanding | 174.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $0.57 |
Book Value | $4.19 |
P/E Ratio | 37.2x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 35.4x |
Operating Margin | 2.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.